A Safety, Tolerability, and Efficacy Study of E-islet 01 in Participants With Type 1 Diabetes

Clinical trial NCT07126873 · RECRUITING

Trial details

NCT number: NCT07126873
Sponsor: EndoCell Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 1 Impaired Hypoglycemic Awareness Severe Hypoglycemia

Start date: 2025-08-11
Primary completion: 2027-12-31
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.